We’ve rebranded some of our products, learn more ›

CODEX® is now PhenoCycler,
Phenoptics™ is now Phenolmager.

Rapid Development of Spatial Signatures as Predictive Biomarkers for Immunotherapy Response

November 23, 2022

The emergence of new immunotherapies as the first line of treatment for cancer, necessitates the development of clinically useful biomarkers to identify patients who will benefit.  Join this webinar to learn more about spatial signatures, biomarkers based on spatial relationships and protein co-expression on specific cellular subsets that are assessed within the context of the tumor immune microenvironment (TiME), which have demonstrated higher accuracy in predicting response to immunotherapies. Our speaker Alessio Colombo, Technical Applications Scientist will also discuss Akoya’s new multiplex panels based on novel protein chemistry that can accelerate the development of spatial signatures, simplifying the pathway to improved stratification to immunotherapy response.




alessio colombo

Alessio Colombo, PhD

Application Scientist
Akoya Biosciences

Alessio Colombo received his doctorate from the Mario Negri Institute (Milan) in 2007. He then completed a postdoctoral appointment at the German Center for Neurodegenerative Disorders (DZNE) in Munich. During this time, he applied state-of-the-art imaging and proteomic analysis to investigate the molecular mechanisms underlying neurodegeneration in the human brain. In 2015 Alessio was promoted to the role of staff scientist and extended his interest to rare lysosomal storage disorders affecting the brain, consolidating his expertise in imaging techniques as the main tool for his scientific questions. In 2021 Alessio joined Akoya as an Application Scientist responsible for the EMEA region.